(1888PressRelease)
May 17, 2008 - Medical device companies bank their futures on successful innovation and executives at medical device companies increasingly realize the importance of taking a more strategic and direct role in the creation and management of a company’s Intellectual Property. InfoStrength is supporting this proactive approach by helping companies like Advanced Liquid Logic manage knowledge and innovation as a critical component of a value creation strategy with InfoStrength Smart Enterprise Suite.
“The key to our company’s success is execution. InfoStrength SES is a strategic component to executing our business plan,” said Rich West, CEO of Advanced Liquid Logic. “InfoStrength SES has demonstrated the ability to secure and manage our intellectual knowledge in a regulated environment, give us management control over operations and to flexibly grow with our evolving needs.”
InfoStrength Smart Enterprise Suite is a full featured knowledge and process management solution that delivers a strategic framework for managing medical device business operations, meeting regulatory and compliance needs, and securing Intellectual Property.
About InfoStrength
InfoStrength®, Inc., exclusively serving biotechnology, pharmaceutical and medical device companies with internationally recognized regulatory expertise, developed InfoStrength® Smart Enterprise Suite (SES) with an innovative software development methodology specifically created for FDA regulated environments. InfoStrength SES is a configurable, modular, web-based application solution specifically designed to address business and regulatory initiatives of life science companies. InfoStrength® SES enables sharing critical information while ensuring Intellectual Property management control, milestone accountability and market differentiating collaboration. The InfoStrength® solution delivers document, project and process management along with regulatory compliance controls and a robust validation package.
